Intco Medical Technology Co., Ltd.
300677
Rank in Stocks
#4031
Intco Medical Technology Co., Ltd. is a company dedicated to the development,... Intco Medical Technology Co., Ltd. is a company dedicated to the development, manufacturing, and worldwide distribution of both single-use medical products and durable medical equipment, serving markets within China and internationally. Their extensive product portfolio includes a variety of personal protective equipment like gloves, face masks, and shields, as well as essential clinical supplies such as ECG electrodes, medical apparel (e.g., isolation gowns), and hand hygiene solutions in both gel and spray forms. The company also produces specialized surgical components, including grounding pads, electrosurgical pencils, ESU cables, tip cleaners, and TENS electrodes. Beyond disposables, Intco Medical supplies a range of robust medical devices, notably mobility aids such as wheelchairs and scooters, along with other general medical apparatus. Their offerings further extend to temperature therapy items, emergency treatment provisions, products for maternal and infant care, and various home healthcare solutions. Established in 2009 and headquartered in Zibo, China, the company underwent a formal corporate name update in January 2020, maintaining its designation as Intco Medical Technology Co., Ltd.
Share Price
$6.17
Market Cap
$4.04B
Change (1 day)
-3.14%
Change (1 year)
5.47%
Country
CN
Trade Intco Medical Technology Co., Ltd. (300677)
Category
Healthcare
P/E ratio for Intco Medical Technology Co., Ltd. (300677)
P/E ratio as of October 2026 TTM: 24.48
According to Intco Medical Technology Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 24.48. At the end of 2023 the company had a P/E ratio of 41.05.
P/E ratio history for Intco Medical Technology Co., Ltd. from 2013 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 24.48 | 118.79% |
| 2024 | 11.19 | -72.75% |
| 2023 | 41.05 | 92.51% |
| 2022 | 21.32 | 403.22% |
| 2021 | 4.24 | -10.96% |
| 2020 | 4.76 | -73.85% |
| 2019 | 18.20 | 20.80% |
| 2018 | 15.07 | -46.92% |
| 2017 | 28.39 | 14.32% |
| 2016 | 24.83 | -15.47% |
| 2015 | 29.38 | -40.48% |
| 2014 | 49.35 | -66.42% |
| 2013 | 146.96 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 47.48 | 93.95% |
US
|
|
| 27.43 | 12.02% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 132.38% |
US
|
|
| - | - |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.